1) Adjuvant radiotherapy versus observation alone for patients at risk of lymph node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di lulio J, Smithers BM et al. Lancet Oncology. 2012; 13(6): 589-97.

2) Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer. Salama, JK, Haddad, RI, Kies, MS, et al. International Journal of Radiation Oncology Biology Physics. 2009; 75(3):725-733.

3) Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice? Agarwal JP. Gupta T. Kalyani N. Budrukkar A. Laskar SG. Murthy V. Kumar P. Narohna V. Pai P. Chaturvedi P. D’cruz AK. Indian Journal of Cancer. 2011; 48(2):148-53.

4) Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer. Seng Chuan Ong, Heiko Schöder, Nancy Y. Lee, Snehal G. Patel, Diane Carlson, Matthew Fury, David G. Pfister, Jatin P. Shah, Steven M. Larson, and Dennis H. Kraus. Journal of Nuclear Medicine. 2008; 49(4):532-540.

5) Deferring Planned Neck Dissection Following Chemoradiation for Stage IV Head and Neck Cancer: The Utility of PET-CT.
Jayakar V. Nayak MD, Rohan R. Walvekar, Regiane S. Andrade, Nicole Daamen, Stephen Y. Lai, Athanassios Argiris, Ryan P. Smith, Dwight E. Heron, Robert L. Ferris, Jonas T. Johnson, Barton F. Branstetter. The Laryngoscope. 2007; 117(12): 2129–2134.

6) How Much Radiation is the Chemotherapy Worth in Advanced Head and Neck Cancer? Kasibhatla, M, Brizel, DM, et al. International Journal of Radiation Oncology Biology Physics. 2007; 68(5):1491-1495.

7) Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. K. Kian Ang, Jonathan Harris, Richard Wheeler, Randal Weber, David I. Rosenthal, Phuc Felix Nguyen-Tân, William H. Westra, et al. New England Journal of Medicine. 2010; 363:24-35.

8) Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis. Mitchell Machtay, MD, Jennifer Moughan, MS, Andrew Farach, MD, Elizabeth Martin-O’Meara, BS, RT(R)(T)
James Galvin, PhD, Adam S. Garden, MD, Randal S. Weber, MD, Jay S. Cooper, MD, Arlene Forastiere, MD, K. Kian Ang, MD. International Journal of Radiation Oncology Biology Physics. 2012; 84(4):983-989.

9) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, Blot E, Rives M, Reyt E, Tourani JM, Geoffrois L, Peyrade F, Guichard F, Chevalier D, Babin E, Lang P, Janot F, Calais G, Garaud P, Bardet E. Journal of Clinical Oncology. 2013; 31(7):853-9.

10) Neck spasm after chemoradiotherapy for head and neck cancer: Natural history and dosimetric correlates. Klaudia U. Hunter, Francis Worden, Carol Bradford, Mark Prince, Scott McLean, Gregory Wolf, Douglas B. Chepeha, Avraham Eisbruch.  Head and Neck. 2013; Published Online; April 4 2013.

11) Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. International Journal of Radiation Oncology Biology Physics. 2013;85(4):941-7.

12) Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer. Jan B. Vermorken, Ricard Mesia, Fernando Rivera, Eva Remenar, Andrzej Kawecki, Sylvie Rottey, Jozsef Erfan, et al. New England Journal of Medicine. 2008; 359:1116-1127.

13) Postoperative Irradiation for Squamous Cell Carcinoma of the Head and Neck:  an Analysis of Treatment Results and Complications. Amdur, RJ, Parsons, JT, Mendenhall, WM, et al. International Journal of Radiation Oncology Biology Physics. 1989;16(1):25-36.

14) Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Mendenhall WM, Amdur RJ, Hinerman RW, Cognetta AB, Mendenhall NP. Laryngoscope. 2009;119(10):1994-9.

15) Results of a Prospective Study of Positron Emission Tomography-Directed Management of Residual Nodal Abnormalities in Node-Positive Head and Neck Cancer After Definitive Radiotherapy With Or Without Systemic Therapy. Porceddu, SV,  Pryor, DI, et al. Head & Neck. 2011;In Press Online January 14.

16) Transoral Robotic Surgery and Human Papillomavirus Status: Oncologic Results. Cohen, MA, Weinstein, GS, O’Malley, Jr, BW, Feldman, M, Quon, H. Head and Neck. 2011 Apr;33(4):573-80.

17) Transoral Robotic Surgery for Oropharyngeal Carcinoma and its Impact on Patient-Reported Quality of Life and Function. Leonhardt, FD, Quon, H, Abrahao, M, O’Malley, Jr, BW, Weinstein, GS. Head and Neck. 2012;34(2):146-54.